Results 1 - 20 of 30 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: magazinearticle
|
|
US FDA blocks Alnylam's bid for label expansion of Onpattro (patisiran)PharmaBiz, 2023-10Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 2 |
Material Type: magazinearticle
|
|
Ionis Pharma completes enrollment in phase 3 CARDIO-TTRansform study of eplontersen in patients with TTR-mediated amyloid cardiomyopathyPharmaBiz, 2023-08Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 3 |
Material Type: magazinearticle
|
|
Bristol Myers Squibb announces US FDA approves addition of positive data from phase 3 VALOR-HCM study to Camzyos labelPharmaBiz, 2023-06Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 4 |
Material Type: magazinearticle
|
|
January 2023 Rx Product NewsPharmacy Times Health Systems, 2023-01Copyright MultiMedia Healthcare Inc. 2023Digital Resources/Online E-Resources |
| 5 |
Material Type: magazinearticle
|
|
Regulatory submission of Tafamidis by Pfizer accepted by USFDABioSpectrum, 2019-01Copyright 2019 MM Activ Sci-Tech Communications Pvt. Ltd., distributed by Contify.comDigital Resources/Online E-Resources |
| 6 |
Material Type: magazinearticle
|
|
Pfizer's phase 3 ATTR-ACT study of tafamidis to treat transthyretin cardiomyopathy meets primary endpointPharmaBiz, 2018-03Copyright 2018 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 7 |
Material Type: magazinearticle
|
|
US FDA grants fast track designation to Ionis & AstraZeneca's eplontersen for patients with transthyretin-mediated amyloid cardiomyopathyPharmaBiz, 2024-02Copyright 2024 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 8 |
Material Type: magazinearticle
|
|
US FDA grants De Novo approval to Viz.ai's AI algorithm for hypertrophic cardiomyopathyPharmaBiz, 2023-08Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 9 |
Material Type: magazinearticle
|
|
Ionis Pharma expands collaboration with AstraZeneca to include exclusive rights to commercialize eplontersen in Latin AmericaPharmaBiz, 2023-07Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 10 |
Material Type: magazinearticle
|
|
US FDA grants Fast Track & Orphan Drug designations to Rocket Pharma's RP-A601 gene therapy for PKP2 arrhythmogenic cardiomyopathyPharmaBiz, 2023-06Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 11 |
Material Type: magazinearticle
|
|
EMA committee recommends approval of Bristol Myers Squibb's Camzyos to treat symptomatic obstructive HCMPharmaBiz, 2023-04Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 12 |
Material Type: magazinearticle
|
|
AstraZeneca & Ionis' Wainua gets US FDA approval for treatment polyneuropathy hATTR-PN in adultsPharmaBiz, 2023-12Copyright 2023 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 13 |
Material Type: magazinearticle
|
|
FDA Approves New Treatments for Heart Disease Caused by Serious Rare DiseaseR & D : reading for the R & D community, 2019-05Copyright Advantage Business Media May 7, 2019 ;ISSN: 0746-9179Full text available |
| 14 |
Material Type: magazinearticle
|
|
Pfizer gets USFDA approval for Vyndaqel and VyndamaxBioSpectrum, 2019-05Copyright 2019 MM Activ Sci-Tech Communications Pvt. Ltd., distributed by Contify.comDigital Resources/Online E-Resources |
| 15 |
Material Type: magazinearticle
|
|
Researchers Discover First Treatment to Improve Survival in Rare Heart ConditionR & D : reading for the R & D community, 2018-08Copyright Advantage Business Media Aug 28, 2018 ;ISSN: 0746-9179Full text available |
| 16 |
Material Type: magazinearticle
|
|
Pfizer presents positive results from Tafamidis phase 3 ATTR-ACT study at ESC Congress 2018PharmaBiz, 2018-08Copyright 2018 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 17 |
Material Type: magazinearticle
|
|
Drug Reduces Deaths from Underdiagnosed Form of Heart FailureR & D : reading for the R & D community, 2018-08Copyright Advantage Business Media Aug 27, 2018 ;ISSN: 0746-9179Full text available |
| 18 |
Material Type: magazinearticle
|
|
BioVentrix gets FDA IDE nod to initiate ALIVE studyPharmaBiz, 2016-06Copyright 2010 Saffron Media Pvt. LtdDigital Resources/Online E-Resources |
| 19 |
Material Type: magazinearticle
|
|
Pfizer's tafamidis receives US FDA breakthrough therapy status to treat patients with transthyretin cardiomyopathyPharmaBiz, 2018-05Copyright 2018 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
| 20 |
Material Type: magazinearticle
|
|
Capricor gets $3.4 mn grant from CIRM to support its phase I/II HOPE-Duchenne studyPharmaBiz, 2016-03Copyright 2010 Saffron Media Pvt. LtdDigital Resources/Online E-Resources |
Results 1 - 20 of 30 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2016 (1)
- 2016 To 2016 (2)
- 2017 To 2017 (1)
- 2018 To 2019 (15)
- After 2019 (12)
-
More options
Subject
- Heart Failure (15)
- Amyloidosis (10)
- Product Development (8)
- Patients (8)
- Heart (8)
- Disease (8)
- Mortality (8)
- Regulatory Approval (7)
- Rare Diseases (6)
- Proteins (6)
- Cardiovascular Disease (5)
- R&d (5)
- Research & Development (5)
- Hospitalization (4)
- Quality Of Life (4)
- Clinical Trials (3)
- Cancer Therapies (3)
- Nervous System (3)
-
More options
Databases
Journal Title
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||